Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications

BioFactors

Volumn 19, Issue 3-4, 2003, Pages 155-163

  Bartalena, Luigi ^a   Tanda, Maria Laura ^a   Piantanida, Eliana ^a   Lai, Adriana ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Allopurinol; Graves' ophthalmopathy; Hydrogen peroxide; Nicotinamide; Pentoxifylline; Superoxide

Indexed keywords

ALLOPURINOL; GLYCOSAMINOGLYCAN; HEAT SHOCK PROTEIN 72; HLA DR ANTIGEN; HYDROGEN PEROXIDE; NICOTINAMIDE; PENTOXIFYLLINE; SUPEROXIDE;

ADIPOCYTE; ADIPOSE TISSUE; BIOAVAILABILITY; CELL INFILTRATION; CELL PROLIFERATION; CIGARETTE SMOKING; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ENDOCRINE OPHTHALMOPATHY; ENVIRONMENTAL FACTOR; EXTRAOCULAR MUSCLE; FIBROBLAST; HUMAN; IN VITRO STUDY; MOLECULAR RECOGNITION; OXIDATIVE STRESS; PRIORITY JOURNAL; REDUCTION; T LYMPHOCYTE;

EID: 0842264910     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520190308     Document Type: Conference Paper

References (29)

1. L. Bartalena, A. Pinchera and C. Marcocci, Management of Graves' ophthalmopathy: reality and perspectives, Endocr Rev 21 (2000), 168-199.
2. H.B. Burch and L. Wartofsky, Graves' ophthalmopathy: current concepts regarding pathogenesis and management, Endocr Rev 14 (1993), 747-793.
3. S.H. Khan, I. Emerit and J. Feingold, Superoxide and hydrogen peroxide production by macrophages of New Zealand black mice, Free Radic Biol Med 8 (1990), 339-345.
4. J.M. McCord and K. Wong, Phagocyte-produced free radicals. In Oxygen free radicals and tissue damage, Ciba Foundation Symposium, Excerpta Medica, Amsterdam (1979), 343-351.
5. L. Bartalena, C. Marcocci and A. Pinchera, Management of thyroid eye disease, Eur J Nucl Med 29(2) (2002), S458-S465.
6. L. Bartalena, C. Marcocci and A. Pinchera, Treating severe Graves' ophthalmopathy, Bailliere's Clin Endocrinol Metab 11 (1997), 521-536.
7. C. Marcocci, L. Bartalena, M.L. Tanda, L. Manetti, E. Dell'Unto, R. Rocchi, G. Barbesino, B. Mazzi, M.P. Bartolomei, P. Lepri, F. Cartei, M. Nardi and A. Pinchera, Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study, J Clin Endocrinol Metab 86 (2001), 3562-3567.
8. L. Bartalena, M.L. Tanda, A. Medea, C. Marcocci and A. Pinchera, Novel approaches to the management of Graves' ophthalmopathy, Hormones 1 (2002), 76-90.
9. L. Bartalena, C. Marcocci and A. Pinchera, Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy, J Clin Endocrinol Metab 81 (1996), 446-448.
10. L. Bartalena, C. Marcocci and A. Pinchera, Graves' ophthalmopathy: a preventable disease? Eur J Endocrinol 146 (2002), 457-461.
11. W.M. Wiersinga and L. Bartalena, Epidemiology and prevention of Graves' ophthalmopathy, Thyroid 12 (2002), 855-860.
12. R.A. Metcalfe and A.P. Weetman, Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy, Clin Endocrinol (Oxf) 40 (1994), 67-72.
13. A.C.K. Cheng, C.P. Pang, A.T.S. Leung, J.K.H. Chua, D.S.P. Fan and D.S.C. Lam, The association between cigarette smoking and ocular diseases, Hong Kong Med J 6 (2000), 195-202.
14. H.B. Burch, S. Lahiri, R.S. Bahn and S. Barnes, Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy, Exp Eye Res 65 (1997), 311-316.
15. Y. Hiromatsu, D. Yang, I. Miyake, M. Koga, J. Kameo, M. Sato, Y. Inoue and K. Nonaka, Nicotinamide decreases cytokine-induced activation of orbital fibroblasts from patients with thyroid-associated ophthalmopathy, J Clin Endocrinol Metab 83 (1998), 121-124.
16. V.B. Bhat and K.M. Madyastha, Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline, Biochem Biophys Res Commun 288 (2001), 1212-1217.
17. C-C. Chang, T-C. Chang, S.C.S. Kao, Y-F. Kuo and L-F. Chien, Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema, Acta Endocrinol (Copenh) 129 (1993), 322-327.
18. J.M. Korducki, S.J. Loftus and R.S. Bahn, Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts, Invest Ophthalmol Vis Sci 33 (1992), 2037-2042.
19. T.J. Smith, R.S. Bahn, C.A. Gorman and M. Cheavens, Stimulation of glycosaminoglycan accumulation by interferon γ in cultured human retroocular fibroblasts, J Clin Endocrinol Metab 72 (1999), 1169-1171.
20. R. Lu, P. Wang, L. Wartofsky, B.D. Sutton, J.L. Zweier, R.S. Bahn, J. Garrity and K.D. Burman, Oxygen free radicals in interleulin-1β-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients, Thyroid 9 (1999), 297-303.
21. A.E. Heufelder, B.E. Wenzel and R.S. Bahn, Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts, J Clin Endocrinol Metab 74 (1992), 737-742.
22. A.E. Heufelder, T.J. Smith, C.A. Gorman and R.S. Bahn, Increased induction of HLA-DR by interferon-γ in cultured retroocular fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxedema, J Clin Endocrinol Metab 73 (1991), 307-313.
23. Y. Hiromatsu, M. Sato, K. Yamada and K. Nonaka, Nicotinamide and 3-amidobenzamide inhibit recombinant interferon-γ-induced HLA-DR antigen expression, but non HLA-A, B, C antigen expression, on cultured human thyroid cells, Clin Endocrinol 36 (1992), 91-95.
24. Y. Hiromatsu, M. Sato, K. Tanaka, N. Ishisaka, J. Kamachi and K. Nonaka, Inhibitory effects of nicotinamide on intercellular adhesion molecule-1 expressio on cultured human thyroid cells, Immunology 80 (1993), 330-332.
25. C. Balazs, E. Kiss and N.R. Farid, Inhibitory effect of pentoxifylline on HLA-DR expression and glycosaminoglycan synthesis of retrobulbar fibroblasts induced by interferon gamma, Acta Microbiol Immunol Hung 44 (1997), 173-179.
26. C. Balazs, H. Kiss and N.R. Farid, Inhibitory effect of pentoxifylline on HLA-DR expression and glycosaminoglycan synthesis by retrobulbar fibroblasts, Horm Metab Res 30 (1998), 496-499.
27. S. Nagata and P. Golstein, The Fas death factor, Science 267 (1995), 1449-1456.
28. E.A. Bouzas, P. Karadimas, G. Mastorakos and D.A. Koutras, Antioxidant agents in the treatment of Graves' ophthalmopathy, Am J Ophthalmol 129 (2000), 618-622.
29. C. Balazs, E. Kiss, A. Vamos, I. Molnar and N.R. Farid, Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO): a pilot study, J Clin Endocrinol Metab 82 (1997), 1999-2002.